TLRY
Tilray Brands, Inc.NASDAQHealthcare$6.55+6.68%ClosedMarket Cap: $761.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.45
P/S
0.70
EV/EBITDA
-0.43
DCF Value
$-38.66
FCF Yield
-11.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
27.7%
Operating Margin
-184.0%
Net Margin
-163.6%
ROE
-91.0%
ROA
-87.2%
ROIC
-101.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2026 | $206.7M | 26.6% | $-26.4M | $0.00 | $0.00 | — |
| Q2 2026 | $303.9M | 26.4% | $-31.1M | $-62.8M | $-0.57 | — |
| Q1 2026 | $287.8M | 27.4% | $2.9M | $-442.3K | $-0.00 | — |
| Q4 2025 | $308.1M | 30.1% | $-1.98B | $-1.75B | $-17.80 | — |
| FY 2025 | $1.13B | 29.3% | $-3.13B | $-3.00B | $-33.80 | — |
| Q3 2025 | $268.3M | 28.0% | $-1.10B | $-1.14B | $-12.60 | — |
| Q2 2025 | $295.1M | 29.0% | $-59.1M | $-119.4M | $-1.40 | — |
| Q1 2025 | $269.8M | 29.8% | $-49.3M | $-52.8M | $-0.54 | — |
| Q4 2024 | $313.2M | 35.8% | $-22.5M | $-43.3M | $-0.55 | — |
| FY 2024 | $1.07B | 28.3% | $-238.1M | $-333.8M | $-4.50 | — |
| Q3 2024 | $255.6M | 26.2% | $-111.4M | $-125.8M | $-1.63 | — |
| Q2 2024 | $262.4M | 24.5% | $-56.5M | $-66.4M | $-0.95 | — |